Genomic & Biopharma News

Immunotherapy Based on Natural Killer Cells May Soon Begin Clinical Studies

Immuno-Oncology News, 2017-01-03 22:05:22

Abbott set to close $25B St. Jude deal
Abbott set to close $25B St. Jude deal aalidrus Tue, 01/03/2017 - 15:09
Fierce Biotech, 2017-01-03 20:09:48

New cancer drugs offer widely different benefits, study says
New cancer drugs offer widely different benefits, study says esagonowsky Tue, 01/03/2017 - 15:05
Fierce Pharma, 2017-01-03 20:05:44

Sex hormone-sensitive gene complex linked to premenstrual mood disorder
Dysregulated cellular response to estrogen and progesterone suspected.
National Institutes of Health, 2017-01-03 19:15:00

Sanofi says Philippine FDA's demand to stop dengue ads comes as 'complete surprise'
Sanofi says Philippine FDA's demand to stop dengue ads comes as 'complete surprise' esagonowsky Tue, 01/03/2017 - 13:44
Fierce Pharma, 2017-01-03 18:44:10

Parental obesity linked to delays in child development, NIH study suggests
Children of obese mothers were more likely to fail tests of fine motor skill.
National Institutes of Health, 2017-01-03 18:15:00

Intarcia picks up another $206M, teams with Gates Foundation on anti-HIV therapy
Intarcia picks up another $206M, teams with Gates Foundation on anti-HIV therapy aalidrus Tue, 01/03/2017 - 12:28
Fierce Biotech, 2017-01-03 17:28:51

J&J and Actelion's potential deal fix? $260 per share for marketed meds, spinoff for pipeline
J&J and Actelion's potential deal fix? $260 per share for marketed meds, spinoff for pipeline chelfand Tue, 01/03/2017 - 11:33
Fierce Pharma, 2017-01-03 16:33:12

FDA nails a third Wockhardt plant with a warning letter
FDA nails a third Wockhardt plant with a warning letter epalmer Tue, 01/03/2017 - 10:15
Fierce Pharma, 2017-01-03 15:15:48